logo

Biocryst Pharmaceuticals Inc (BCRX)



Trade BCRX now with
  Date
  Headline
8/31/2020 7:12:18 AM BioCryst Pharma: FDA Grants Orphan Drug Designation For BCX9930 For Paroxysmal Nocturnal Hemoglobinuria
8/3/2020 7:21:37 AM BioCryst Receives Fast Track Designation For Its Oral Factor D Inhibitor, BCX9930
7/2/2020 7:13:35 AM BioCryst Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6/2/2020 7:16:40 AM BioCryst Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/27/2020 11:45:03 PM BioCryst Pharma Prices Public Offering Of 18.7 Mln Shares At $4.50/Shr
4/3/2020 7:10:10 AM BioCryst Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2/2020 7:09:24 AM BioCryst Pharma Appoints Anthony Doyle As SVP And CFO
3/16/2020 7:20:37 AM BioCryst Announces New Data From The APeX-2 Trial
2/18/2020 7:15:00 AM BioCryst Pharma Says FDA Accepts NDA For Oral, Once Daily Berotralstat To Prevent HAE Attacks
2/3/2020 7:06:14 AM BioCryst Submits JNDA For Oral, Once Daily Berotralstat For Prophylactic Treatment Of Hereditary Angioedema
1/6/2020 7:13:33 AM BioCryst Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)